Utah Retirement Systems Biogen Inc. Transaction History

Utah Retirement Systems

$8.85 Billion
Q4 2024

A detailed history of Utah Retirement Systems transactions in Biogen Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 24,115 shares of BIIB stock, worth $3.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

24,115

Previous 24,115 -0.0%

Holding current value

$3.39 Million

Previous $4.67 Million 21.12%

% of portfolio

0.04%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $18,907 - $23,680	100 Added 0.42%	24,115 $4.67 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $171,468 - $213,048	-900 Reduced 3.61%	24,015 $5.57 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $22,259 - $26,794	100 Added 0.4%	24,915 $6.45 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $12,411 - $14,008	49 Added 0.2%	24,815 $6.38 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $220,200 - $254,448	-800 Reduced 3.13%	24,766 $7.05 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $25,656 - $29,233	100 Added 0.39%	25,566 $7.11 Million
Q4 2022 Feb 15, 2023	SELL	$252.44 - $306.72 $167,367 - $203,355	-663 Reduced 2.54%	25,466 $7.05 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $19,469 - $26,845	100 Added 0.38%	26,129 $6.98 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $96,885 - $122,070	-500 Reduced 1.88%	26,029 $5.48 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $67,176 - $86,331	-300 Reduced 1.12%	26,529 $6.37 Million
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $481,083 - $627,385	-1,700 Reduced 5.96%	26,829 $7.59 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $155,400 - $248,826	-600 Reduced 2.06%	28,529 $9.88 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $388,720 - $455,408	-1,600 Reduced 5.21%	29,129 $8.15 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $107,498 - $161,811	455 Added 1.5%	30,729 $7.52 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $185,339 - $213,997	-700 Reduced 2.26%	30,274 $8.59 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $801,846 - $1.06 Million	-3,100 Reduced 9.1%	30,974 $8.29 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $80,655 - $102,312	-300 Reduced 0.87%	34,074 $10.8 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $132,036 - $182,442	-600 Reduced 1.72%	34,374 $10.2 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $391,392 - $438,984	-1,800 Reduced 4.89%	34,974 $8.14 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $74,777 - $82,426	-341 Reduced 0.92%	36,774 $8.6 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $86,467 - $135,245	-399 Reduced 1.06%	37,115 $8.77 Million
Q4 2018 Feb 08, 2019	BUY	$278.5 - $352.75 $27,850 - $35,275	100 Added 0.27%	37,514 $11.3 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $469,616 - $614,128	-1,600 Reduced 4.1%	37,414 $13.2 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $128,759 - $153,455	-500 Reduced 1.27%	39,014 $11.3 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $26,013 - $36,791	100 Added 0.25%	39,514 $10.8 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $153,820 - $172,290	500 Added 1.28%	39,414 $12.6 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $10.9 Million - $12.8 Million	38,914	38,914 $12.2 Million

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Biogen Inc. Transaction History